Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
LuciusVersionofAprocitentan:DosageandAdministration,Indications,PrecautionsIndicationAprocitentan is an endothelin receptor antagonist. Used in combination with other antihypertens···【more】
Article source：Captain MedicineRelease date：2025-12-05Recommended：122
LuciusVersionofPalbociclib:DosageandAdministration,Indications,PrecautionsIndicationCapivasertib is a kinase inhibitor. In combination with fulvestrant, it is indicated for the tre···【more】
Article source：Captain MedicineRelease date：2025-12-05Recommended：80
Lucius Version of Belzutifan: Dosage and Administration, Indications, PrecautionsIndicationsBelzutifan is a hypoxia-inducible factor inhibitor indicated for:Von Hippel-Lindau (VHL)···【more】
Article source：Captain MedicineRelease date：2025-12-04Recommended：97
LuciusVersionofRibociclib:DosageandAdministration,Indications,PrecautionsIndicationIndicated for the treatment of adult patients with hormone receptor (HR)-positive, human epiderma···【more】
Article source：Captain MedicineRelease date：2025-12-04Recommended：87
LuciusVersionofElacestrant:DosageandAdministration,Indications,PrecautionsIndicationsElacestrant is an estrogen receptor antagonist indicated for:The treatment of postmenopausal wo···【more】
Article source：Captain MedicineRelease date：2025-12-03Recommended：120
LuciusVersionofResmetirom:DosageandAdministration,Indications,PrecautionsIndicationsResmetirom is a thyroid hormone receptor-beta (THR-β) agonist. When used in combination with die···【more】
Article source：Captain MedicineRelease date：2025-12-03Recommended：106
LuciusVersionofAnagrelide:DosageandAdministration,Indications,PrecautionsIndicationsAnagrelide is a thrombocytopenic agent indicated for the treatment of thrombocythemia secondary ···【more】
Article source：Captain MedicineRelease date：2025-12-02Recommended：87
Lucius Version of Palbociclib: Dosage and Administration, Indications, PrecautionsIndicationsPalbociclib is a kinase inhibitor indicated for the treatment of adult patients with ho···【more】
Article source：Captain MedicineRelease date：2025-12-02Recommended：108
Lucius Version of Sunitinib: Dosage and Administration, Indications, PrecautionsIndicationsSunitinib is a kinase inhibitor indicated for the treatment of:Gastrointestinal stromal t···【more】
Article source：Captain MedicineRelease date：2025-12-01Recommended：70
Lucius Version of Tazemetostat: Dosage and Administration, Indications, PrecautionsIndicationsTazemetostat is a methyltransferase inhibitor indicated for the treatment of:Adult and···【more】
Article source：Captain MedicineRelease date：2025-11-28Recommended：82
Lucius Version of Futibatinib: Dosage and Administration, Indications, PrecautionsIndicationsFutibatinib is a kinase inhibitor indicated for the treatment of adult patients with pr···【more】
Article source：Captain MedicineRelease date：2025-11-28Recommended：93
Correct understanding of drug properties is of guiding significance for treatment decisions.Are the side effects of abuxitinib serious?Understanding the potential impact of treatme···【more】
Article source：Captain MedicineRelease date：2025-06-11Recommended：159
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：1702025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：4092024-09-07
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：1642025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：1842025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：1642025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：2002025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：1782025-01-12
The Cure SMA Foundation, a global leading non-profit organization dedicated to spinal muscular atrop···【more】
Recommended：1732025-27-11
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp:
